학술논문

Concurrent OX40 and CD30 ligand blockade abrogates the CD4-driven autoimmunity associated with CTLA4 and PD1 blockade while preserving excellent anti-CD8 tumor immunity
Document Type
Article
Source
In: Journal of Immunology. (Journal of Immunology, 1 August 2017, 199(3):974-981)
Subject
Language
English
ISSN
15506606
00221767